Could an old antidepressant tweak immune cells in COVID-19?
NCT ID NCT04590222
First seen Apr 25, 2026 · Last updated Jun 12, 2026 · Updated 10 times
Summary
This study looked at how phenelzine, a monoamine oxidase inhibitor, affects immune cells in 51 adults with COVID-19. Researchers measured changes in T cells and monocytes to understand immune activation. The goal was to gather knowledge, not to treat or cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV2 INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Bicêtre
Le Kremlin-Bicêtre, 94270, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.